A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
3 Iodobenzylguanidine has been studied across 8 research domains including ⏳ Longevity & Aging, 🔬 Oncology, 🫘 Kidney, 🧠 Neuroprotection, 🧠 Cognitive. The primary research focus is ⏳ Longevity & Aging with 40% of studies addressing this area.
The following compounds share molecular targets with 3 Iodobenzylguanidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for 3 Iodobenzylguanidine is generated deterministically from 20 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.